Harmonizing EPA And Industry Needs: EtO Emissions

The EPA and medtech industry want the same things: Cleaner air and a steady supply of medical devices. So how do they reconcile their differences?

wooden factory with magnifying glass on blue background
• Source: Shutterstock

As the comment period for the US Environmental Protection Agency’s proposed rules on new ethylene oxide (EtO) emissions standards closes, AdvaMed CEO Scott Whitaker wants to enter discussions with the agency as "partners, not adversaries."

In April, the EPA proposed two rules to limit exposure to ethylene oxide (EtO) emissions from commercial sterilizers. The first...

More from ESG

More from Medtech Insight

Medtronic, Philips Cement New Pact To Embed Next-Gen Tech In Monitoring Platforms

 
• By 

Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.

Bivacor Rotary Heart Could Upend The Artificial Heart Market, If It Reaches Its Destination

 
• By 

Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.

Study: FDA’s Breakthrough Path Speeds Access, But Raises Safety Questions

 
• By 

Research recently published in JAMA Internal Medicine found that the FDA met its review timeline goals for the majority of breakthrough devices – but also revealed some apparent shortcomings in safety data supporting the submissions.